⌘K

09:03:18·24d

SECFilingvia Quantisnow

SEC Form S-8 POS filed by Apellis Pharmaceuticals Inc.

ByQuantisnow·Wall Street's wire, on your screen.

APLS· Apellis Pharmaceuticals Inc.

Health Care

Original source

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Related

Amendment: SEC Form SCHEDULE 13G/A filed by Apellis Pharmaceuticals Inc.
SEC Form 15-12G filed by Apellis Pharmaceuticals Inc.
Director Dunlop A. Sinclair returned 20,311 shares to the company, closing all direct ownership in the company (SEC Form 4) (tax withholding)
VP/Chief Accounting Officer Chopas James George was granted 38,244 shares and returned 76,650 shares to the company, closing all direct ownership in the company (SEC Form 4) to satisfy withholding tax
Director Dolsten Mikael returned 14,312 shares to the company, closing all direct ownership in the company (SEC Form 4) (withholding tax)

SEC Form S-8 POS filed by Apellis Pharmaceuticals Inc. | Quantisnow